NRG
80
3
ADBE
55
4
KLAC
65
2
NKE
42
2
STT
56
8
PHM
74
3
IR
71
-12
HIG
72
2
CF
35
2
APA
32
2
AZO
46
-2
MTB
55
3
EXR
55
5
GOOG
91
2
STI
55
-3
XRAY
19
-9
AAPL
71
10
EXPD
45
5
EIX
58
2
INTC
35
3
NRG
80
3
ADBE
55
4
KLAC
65
2
NKE
42
2
STT
56
8
PHM
74
3
IR
71
-12
HIG
72
2
CF
35
2
APA
32
2
AZO
46
-2
MTB
55
3
EXR
55
5
GOOG
91
2
STI
55
-3
XRAY
19
-9
AAPL
71
10
EXPD
45
5
EIX
58
2
INTC
35
3
Financhill
Back

The Oncology Institute 10K Form

Sell
38

TOI
The Oncology Institute

Last Price:
0.94
Seasonality Move:
32.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOI News And Ratings

See the #1 stock for the next 7 days that we like better than TOI

TOI Financial Statistics

Sales & Book Value

Annual Sales: $324.24M
Cash Flow: $-4.75M
Price / Cash Flow: 0
Annual Sales: $0.77
Price / Book: 1.39

Profitability

EPS (TTM): -0.92000
Net Income (TTM): $-83.07M
Gross Margin: $59.57M
Return on Equity: -95.44%
Return on Assets: -36%

The Oncology Institute Earnings Forecast

Key The Oncology Institute Financial Ratios

  • The Gross Profit Margin over the past 5 years for TOI is 18.37%.
  • The Selling, General & Administrative Expenses for TOI have been equal to 35.11% of Gross Profit Margin.
  • The Interest Expense is -8.16% of Operating Income.
  • The Net Earning history of TOI is -25.62% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

The Oncology Institute Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: TOI
Website: theoncologyinstitute.com

Debt

Debt-to-Equity Ratio: 1.52
Current Ratio: 4.12
Quick Ratio: 3.62

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOI Technical Analysis vs Fundamental Analysis

Sell
38
The Oncology Institute (TOI) is a Sell

Is The Oncology Institute a Buy or a Sell?